Swimlane Communications Brand Identity and Guidelines
What I did: Corporate Brand Strategy, Creative Direction, Design
A bold new brand identity for Swimlane Communications, an emerging public relations firm specializing in strategic communications and storytelling. Designed to break away from the sea of sameness, the brand evokes a sense of action, agility, and precision.
Sage Therapeutics Postpartum Depression (PPD) Quote Book
What I did: Corporate Brand Strategy, Storytelling, Creative Direction, Design
Printed, hardcover quote book celebrating ZURZUVAE’s impact through real stories and reflections from the PPD community. Created to inspire and emotionally engage Sage’s Board of Directors and leadership, it reinforces the organization’s purpose and serves as a powerful reminder of the good it stands for and the impact it has made.
Sage Therapeutics Patient-Story Banners
What I did: Corporate Brand Strategy, Creative Direction, Design
Empowering internal patient-story banners that bring Sage's guiding principle, 'The Time is Now,' to life while highlighting and humanizing its core disease areas.
Sage Therapeutics Corporate Factsheet
What I did: Corporate Brand Strategy, Messaging, Creative Direction, Design
Engaging corporate factsheet designed to introduce Sage and serve as a leave-behind for key stakeholders at pivotal medical and patient-focused meetings and conferences.
Sage Therapeutics J.P. Morgan Healthcare Conference Executive’s Presentation
What I did: Corporate Brand Strategy, Creative Direction, Art Direction, Design
Strategically designed presentation slides showcase Sage’s business objectives, product updates, and insights into its core disease areas. Thoughtful design and use of brand assets ensure Sage stands out from the sea of sameness at Biotech’s premier annual conference.
Apellis Pharmaceuticals Investor Relations Webcast Invitations
What I did: Creative Direction, Design
Attention-grabbing investor relations invitations designed to elevate the Apellis brand, create lasting impressions, and position Apellis as a standout leader in the competitive biotech space.
Alnylam Pharmaceuticals Mechanism of Action (MOA) Brochure
What I did: Creative Direction, Design
MOA brochure explaining Alnylam’s revolutionary RNAi scientific platform and its promising investigational drug, ALN-AT3. Designed to restore the delicate balance of blood clotting, ALN-AT3 offers new hope for individuals with hemophilia, bringing the potential for a transformative shift in treatment and outcomes.
